All lobbying filings
PATIENTSACT
PATIENTSACT filed a Q2 termination report for PATIENTSACT on July 8, 2026.
Lobbying for PATIENTSACT · Educate & advocate for patients' safety rights and freedom of choice in treatment options
Filing · LD-2 quarterly report
Q2 termination
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 8, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Illinois
Representation ended
May 28, 2026
The registrant reported terminating its work for this client.
Lobbying activity
2
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.
Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.